AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7825537 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy formula with added selenate (SF+Se)
Number of subjects: 33
Study 2141057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB, 40 micrograms)
Number of subjects: 16
Study 2141057 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (F, 100 micrograms)
Number of subjects: 16
Study 2141057 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ibuprofen and fenoterol (IBF)
Number of subjects: 16
Study 2141057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB)
Number of subjects: 16
Study 2141057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 638411 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary restriction and laxatives
Number of subjects: 0
Study 638411 — intervention group
Group type: COMPARATOR
Intervention: Unprepared patients
Number of subjects: 0
Study 29469601 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02%
Number of subjects: 11
Study 29469601 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 11
Study 27722092 — intervention group
Group type: EXPERIMENTAL
Intervention: Eliglustat
Number of subjects: 30
Study 27722092 — intervention group
Group type: COMPARATOR
Intervention: Imiglucerase
Number of subjects: 30
Study 24937483 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet interventions
Number of subjects: 5612
Study 24937483 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 5612
Study 24937483 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only or alcohol information control
Number of subjects: 5612
Study 22885459 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic navigation (n = 7)
Number of subjects: 17
Study 22885459 — intervention group
Group type: COMPARATOR
Intervention: CT fluoroscopy alone (n = 10)
Number of subjects: 17
Study 20002637 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNTA (20 U)
Number of subjects: 227
Study 20002637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study 19000237 — intervention group
Group type: EXPERIMENTAL
Intervention: After-school program including moderate-to-vigorous physical activity, healthy snacks, homework assistance, and academic enrichment.
Number of subjects: 0
Study 19000237 — intervention group
Group type: COMPARATOR
Intervention: Usual after-school care costs (control condition).
Number of subjects: 0
Study 15867285 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein protein (CAPM)
Number of subjects: 22
Study 15867285 — intervention group
Group type: COMPARATOR
Intervention: Soy protein (SOPM)
Number of subjects: 22
Study 12766967 — intervention group
Group type: EXPERIMENTAL
Intervention: Active irradiation with linearly polarized 0.6-1.6 microm light (0.92 W, 88.3 J)
Number of subjects: 18
Study 12766967 — intervention group
Group type: COMPARATOR
Intervention: Placebo radiation
Number of subjects: 18
Study 12766967 — intervention group
Group type: EXPERIMENTAL
Intervention: Active irradiation
Number of subjects: 18
Study 10631440 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA with propofol/remifentanil
Number of subjects: 60
Study 10631440 — intervention group
Group type: COMPARATOR
Intervention: Balanced anaesthesia with sevoflurane/fentanyl
Number of subjects: 60
Study 7575762 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (0.8 g single daily dose)
Number of subjects: 1
Study 7575762 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (0.4 g two daily doses)
Number of subjects: 1
Study 2256719 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoresistance testing at initiation of therapy
Number of subjects: 50
Study 2256719 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-look status
Number of subjects: 50
Study 2256719 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoresistance testing
Number of subjects: 50
Study 2256719 — intervention group
Group type: COMPARATOR
Intervention: Stage, residual tumour, second-look status, chemoresistance, ploidy and proliferation
Number of subjects: 50
Study 6989684 — intervention group
Group type: EXPERIMENTAL
Intervention: tolciclate 1% cream
Number of subjects: 81
Study 6989684 — intervention group
Group type: COMPARATOR
Intervention: miconazole 2% cream
Number of subjects: 81
Study 6333636 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 686
Study 6333636 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 686
Study 31725638 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram integrating 8 risk factors
Number of subjects: 1110
Study 31725638 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 1110
Study 31725638 — intervention group
Group type: COMPARATOR
Intervention: TNM staging system
Number of subjects: 1110
Study 30289360 — intervention group
Group type: EXPERIMENTAL
Intervention: Organized recess (instructional tasks and supervision)
Number of subjects: 281
Study 30289360 — intervention group
Group type: COMPARATOR
Intervention: Supervised recess (free play with supervision)
Number of subjects: 281
Study 26536843 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (visit to a physician) for high-risk patients
Number of subjects: 0
Study 26536843 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control group) for high-risk patients
Number of subjects: 0
Study 26536843 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk patients (not receiving intervention)
Number of subjects: 0
Study 25284266 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 2
Study 25284266 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 2
Study 22409100 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher feedback
Number of subjects: 0
Study 22409100 — intervention group
Group type: COMPARATOR
Intervention: Lower feedback
Number of subjects: 0
Study 22409100 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased feedback for fluid ability cues
Number of subjects: 0
Study 22409100 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased feedback for crystallized ability cues
Number of subjects: 0
Study 19825430 — intervention group
Group type: EXPERIMENTAL
Intervention: Gore-Tex assisted modified Stamm's gastrostomy (GAMSG)
Number of subjects: 40
Study 19825430 — intervention group
Group type: COMPARATOR
Intervention: Conventional Stamm gastrostomy (CSG)
Number of subjects: 40
Study 18271282 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/day vitamin E (E400)
Number of subjects: 35
Study 18271282 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day vitamin E (E200)
Number of subjects: 35
Study 18271282 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg/day vitamin C (C250)
Number of subjects: 35
Study 18271282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 15673408 — intervention group
Group type: EXPERIMENTAL
Intervention: Pexelizumab bolus (2.0 mg/kg) + placebo infusion
Number of subjects: 914
Study 15673408 — intervention group
Group type: EXPERIMENTAL
Intervention: Pexelizumab bolus (2.0 mg/kg) + pexelizumab infusion (0.05 mg/kg/hour for 24 hours)
Number of subjects: 914
Study 15673408 — intervention group
Group type: COMPARATOR
Intervention: Placebo bolus + placebo infusion
Number of subjects: 914
Study 12151925 — intervention group
Group type: EXPERIMENTAL
Intervention: P6 acupoint injections
Number of subjects: 187
Study 12151925 — intervention group
Group type: COMPARATOR
Intervention: Droperidol
Number of subjects: 187
Study 10458212 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine-cisplatin
Number of subjects: 135
Study 10458212 — intervention group
Group type: COMPARATOR
Intervention: etoposide-cisplatin
Number of subjects: 135
Study 9497632 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Nd: YAG laser
Number of subjects: 6
Study 9497632 — intervention group
Group type: COMPARATOR
Intervention: Ferric sulphate (13.3%)
Number of subjects: 6
Study 9497632 — intervention group
Group type: COMPARATOR
Intervention: Aluminium chloride (25%)
Number of subjects: 6
Study 2240495 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclofos 70 mg/kg orally 90 minutes before operation
Number of subjects: 263
Study 2240495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study 206923 — intervention group
Group type: EXPERIMENTAL
Intervention: TZM 0.25 mg
Number of subjects: 8
Study 206923 — intervention group
Group type: EXPERIMENTAL
Intervention: FZP 15 mg
Number of subjects: 8
Study 206923 — intervention group
Group type: COMPARATOR
Intervention: Noise alone
Number of subjects: 8
Study 206923 — intervention group
Group type: COMPARATOR
Intervention: MPD alone
Number of subjects: 8
Study 206923 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise and TZM
Number of subjects: 8
Study 206923 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise and FZP
Number of subjects: 8
Study 206923 — intervention group
Group type: EXPERIMENTAL
Intervention: MPD and TZM
Number of subjects: 8
Study 206923 — intervention group
Group type: EXPERIMENTAL
Intervention: MPD and FZP
Number of subjects: 8
Study 30975195 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodized exercise training
Number of subjects: 50
Study 30975195 — intervention group
Group type: COMPARATOR
Intervention: Non-periodized exercise training (standard guidelines)
Number of subjects: 50
Study 27329506 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily intermittent hypoxia (IH) combined with body weight-supported treadmill training (BWSTT)
Number of subjects: 0
Study 27329506 — intervention group
Group type: COMPARATOR
Intervention: Continuous normoxia (Nx) combined with body weight-supported treadmill training (BWSTT)
Number of subjects: 0
Study 26073353 — intervention group
Group type: EXPERIMENTAL
Intervention: Amfepramone 75 mg daily for 6 months
Number of subjects: 156
Study 26073353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 24172292 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (PHRT; n=15)
Number of subjects: 43
Study 24172292 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training (PHET; n=13)
Number of subjects: 43
Study 24172292 — intervention group
Group type: COMPARATOR
Intervention: Time-control group (PHTC; n=15)
Number of subjects: 43
Study 24172292 — intervention group
Group type: COMPARATOR
Intervention: Normotensive controls (15 matched participants)
Number of subjects: 43
Study 22089106 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated sleep-time blood pressure
Number of subjects: 3344
Study 22089106 — intervention group
Group type: COMPARATOR
Intervention: Awake blood pressure measurements
Number of subjects: 3344
Study 22089106 — intervention group
Group type: EXPERIMENTAL
Intervention: Asleep mean blood pressure
Number of subjects: 3344
Study 19251010 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl with midazolam (n = 138)
Number of subjects: 287
Study 19251010 — intervention group
Group type: COMPARATOR
Intervention: Meperidine with midazolam (n = 149)
Number of subjects: 287
Study 19251010 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl with midazolam (lower doses 2-3.5 mg)
Number of subjects: 287
Study 19251010 — intervention group
Group type: COMPARATOR
Intervention: Meperidine with midazolam (lower doses 2-3.5 mg)
Number of subjects: 287
Study 19251010 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl with midazolam (higher doses >= 4 mg)
Number of subjects: 287
Study 19251010 — intervention group
Group type: COMPARATOR
Intervention: Meperidine with midazolam (higher doses >= 4 mg)
Number of subjects: 287
Study 17532891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory-amplitude electric stimulation (SES) group (n=15)
Number of subjects: 30
Study 17532891 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (n=15)
Number of subjects: 30
Study 17532891 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SES and placebo groups
Number of subjects: 30
Study 15470879 — intervention group
Group type: EXPERIMENTAL
Intervention: Luting material PA (Panavia F/ED Primer)
Number of subjects: 144
Study 15470879 — intervention group
Group type: EXPERIMENTAL
Intervention: Luting material VL (Variolink II/Excite)
Number of subjects: 144
Study 15470879 — intervention group
Group type: EXPERIMENTAL
Intervention: Luting material DY (Dyract/Prime & Bond NT)
Number of subjects: 144
Study 15470879 — intervention group
Group type: EXPERIMENTAL
Intervention: Luting material FU (Fuji Plus/GC Cavity Conditioner)
Number of subjects: 144
Study 15470879 — intervention group
Group type: COMPARATOR
Intervention: Composite luting materials PA and VL
Number of subjects: 144
Study 15470879 — intervention group
Group type: COMPARATOR
Intervention: RMGIC (resin-modified glass ionomer cement)
Number of subjects: 144
Study 10919304 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 15 mg + morphine 5 mg + intraarticular methylprednisolone 40 mg
Number of subjects: 36
Study 10919304 — intervention group
Group type: COMPARATOR
Intervention: intraarticular saline
Number of subjects: 36
Study 9010697 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril 25 mg b.i.d.
Number of subjects: 24
Study 9010697 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril 100 mg b.i.d.
Number of subjects: 24
Study 9010697 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril 400 mg b.i.d.
Number of subjects: 24
Study 9010697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1490141 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (100 mg/day initially)
Number of subjects: 50
Study 1490141 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B1 (100 mg/day)
Number of subjects: 50
Study 2992238 — intervention group
Group type: EXPERIMENTAL
Intervention: Silk sutures
Number of subjects: 1011
Study 2992238 — intervention group
Group type: COMPARATOR
Intervention: Polyglycolic acid (PGA) sutures
Number of subjects: 1011
Study 29690917 — intervention group
Group type: EXPERIMENTAL
Intervention: Substantial weight loss (SWL; 10-15% body weight) using a modified very low energy diet (VLED) program
Number of subjects: 164
Study 29690917 — intervention group
Group type: COMPARATOR
Intervention: Modest weight loss (MWL; ≤3% body weight) using a hypocaloric diet
Number of subjects: 164
Study 28211285 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) combined with femoral nerve block (FNB) - 150 mL mixture of ropivacaine 2.0 mg/mL + ketorolac 30 mg + adrenaline 10 μg/mL
Number of subjects: 254
Study 28211285 — intervention group
Group type: COMPARATOR
Intervention: Control group - FNB only
Number of subjects: 254
Study 28211285 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) combined with femoral nerve block (FNB)
Number of subjects: 254
Study 25308884 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) augmented by Neuromuscular Electrical Stimulation (NMES)
Number of subjects: 37
Study 25308884 — intervention group
Group type: COMPARATOR
Intervention: Progressive Resistance Training (PRT)
Number of subjects: 37
Study 23579078 — intervention group
Group type: EXPERIMENTAL
Intervention: CM-full (n=64)
Number of subjects: 131
Study 23579078 — intervention group
Group type: COMPARATOR
Intervention: CM-lite (n=67)
Number of subjects: 131
Study 23579078 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CM-full and CM-lite
Number of subjects: 131
Study 22035223 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen persufflation for 2 hours prior to transplantation
Number of subjects: 116
Study 22035223 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure (cold storage without further intervention)
Number of subjects: 116
Study 22035223 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen persufflation
Number of subjects: 116
Study 18502300 — intervention group
Group type: EXPERIMENTAL
Intervention: succinobucol
Number of subjects: 6144
Study 16802265 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopy performed by nurse endoscopists
Number of subjects: 367
Study 16802265 — intervention group
Group type: COMPARATOR
Intervention: Endoscopy performed by doctor endoscopists
Number of subjects: 367
Study 12972476 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibandronate 2 mg
Number of subjects: 629
Study 12972476 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibandronate 1 mg
Number of subjects: 629
Study 12972476 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibandronate 0.5 mg
Number of subjects: 629
Study 12972476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 629
Study 12972476 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of ibandronate
Number of subjects: 629
Study 12972476 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibandronate
Number of subjects: 629
Study 10712859 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta4, 16‐androstadien‐3‐one
Number of subjects: 0
Study 10712859 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,3,5(10)16‐estratetraen‐3‐ol
Number of subjects: 0
Study 10712859 — intervention group
Group type: COMPARATOR
Intervention: Clove oil carrier solution
Number of subjects: 0
Study 8665577 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-462 20 mg
Number of subjects: 65
Study 8665577 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-462 40 mg
Number of subjects: 65
Study 8665577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 1388093 — intervention group
Group type: EXPERIMENTAL
Intervention: Provera 500-mg tablet
Number of subjects: 30
Study 1388093 — intervention group
Group type: COMPARATOR
Intervention: Farlutal 500-mg tablet
Number of subjects: 30
Study 1388093 — intervention group
Group type: EXPERIMENTAL
Intervention: Provera 500-mg granule packet
Number of subjects: 30
Study 3916620 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted meal-related insulin therapy (CAMIT = 3-4 injections daily)
Number of subjects: 12
Study 3916620 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (CT = 2-3 injections daily)
Number of subjects: 12
Study 31660706 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole (40 mg/d)
Number of subjects: 160
Study 31660706 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (40 mg/d)
Number of subjects: 160
Study 31660706 — intervention group
Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 160
Study 31660706 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 160
Study 29920214 — intervention group
Group type: EXPERIMENTAL
Intervention: T3 repletion (5 weeks)
Number of subjects: 9
Study 29920214 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 weeks)
Number of subjects: 9
Study 29920214 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin repletion
Number of subjects: 9
Study 27043753 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (content with hyperlinks to videos explaining key genetic concepts)
Number of subjects: 90
Study 27043753 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (translated content with knowledge pearls embedded)
Number of subjects: 90
Study 27043753 — intervention group
Group type: COMPARATOR
Intervention: Group A (control group with exact copy of text from MCG)
Number of subjects: 90
Study 24089320 — intervention group
Group type: EXPERIMENTAL
Intervention: Health insurance-based case-management (trained account managers)
Number of subjects: 100
Study 24089320 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained account managers)
Number of subjects: 100
Study 23757762 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined subthalamic nucleus and substantia nigra pars reticulata stimulation
Number of subjects: 12
Study 23757762 — intervention group
Group type: COMPARATOR
Intervention: Standard subthalamic nucleus stimulation
Number of subjects: 12
Study 20094040 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity-based lifestyle intervention for 3 months
Number of subjects: 21
Study 20094040 — intervention group
Group type: COMPARATOR
Intervention: Lean controls
Number of subjects: 21
Study 18545094 — intervention group
Group type: EXPERIMENTAL
Intervention: More intensive web-based stress management program
Number of subjects: 226
Study 18545094 — intervention group
Group type: EXPERIMENTAL
Intervention: Less intensive web-based stress management program
Number of subjects: 226
Study 18545094 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 226
Study 16507938 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 microg levonorgestrel/20 microg ethinyl estradiol (20LNG group)
Number of subjects: 139
Study 16507938 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 microg levonorgestrel/30 microg ethinyl estradiol (30LNG group)
Number of subjects: 139
Study 16507938 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 microg norethindrone acetate/20 microg ethinyl estradiol (20NETA group)
Number of subjects: 139
Study 16507938 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 microg norethindrone acetate/30 microg ethinyl estradiol (30NETA group)
Number of subjects: 139
Study 12581148 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd‐Yag laser
Number of subjects: 100
Study 12581148 — intervention group
Group type: EXPERIMENTAL
Intervention: Alexandrite laser
Number of subjects: 100
Study 12581148 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 100
Study 10949772 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based practice guidelines
Number of subjects: 0
Study 10949772 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines dissemination
Number of subjects: 0
Study 10949772 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation strategies
Number of subjects: 0
Study 10949772 — intervention group
Group type: EXPERIMENTAL
Intervention: Tools for implementation
Number of subjects: 0
Study 10949772 — intervention group
Group type: EXPERIMENTAL
Intervention: Managed health care influences
Number of subjects: 0
Study 7949691 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance (MR) imaging at rest
Number of subjects: 24
Study 7949691 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance (MR) imaging during active plantar flexion against resistance
Number of subjects: 24
Study 2853441 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% nedocromil sodium nasal spray given four times daily for four weeks
Number of subjects: 38